LexAurum Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LexAurum Advisors's BMY Position: Q2 2026 in Review
LexAurum Advisors reduced its Bristol-Myers Squibb (BMY) stake by 0.52% in Q2 2026, selling an estimated $1.72K and leaving 5,781 shares worth $333K. The position accounts for 0.04% of the portfolio, ranked #321.
LexAurum Advisors first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $352K in Q1 2026. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- LexAurum Advisors held 5,781 shares of Bristol-Myers Squibb worth $333K as of Q2 2026.
- LexAurum Advisors sold 30 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.72K.
- Bristol-Myers Squibb made up 0.04% of LexAurum Advisors's portfolio in Q2 2026, its #321 holding.
- LexAurum Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- LexAurum Advisors's Bristol-Myers Squibb position peaked at $352K in Q1 2026.
- 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on LexAurum Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.